Skip to navigation menu Skip to content
Clinical Trial Search block Test

Allogeneic hematopoietic cell transplantation for patients with non-malignant disorders using Treosulfan, Fludarabine, and Thiotepa

FH9621 TREO TT

  • Condition(s): BMT
  • Phase: II
  • Clinicaltrials.gov ID: NCT03980769

What is the goal of the study?

Allogeneic hematopoietic cell transplantation for patients with non-malignant disorders using Treosulfan, Fludarabine, and Thiotepa

Who can participate in the study?

Everyone

Study Team: